Mechanisms of apoptosis by c-Myc
暂无分享,去创建一个
[1] P. Leder,et al. An embryonically expressed gene is a target for c-Myc regulation via the c-Myc-binding sequence. , 1992, Genes & development.
[2] S. Laster,et al. Bleb formation and F‐actin distribution during mitosis and tumor necrosis factor‐induced apoptosis , 1996, Microscopy research and technique.
[3] A. Bergh,et al. Castration induces apoptosis in the ventral prostate but not in an androgen-sensitive prostatic adenocarcinoma in the rat. , 1994, Cancer research.
[4] M. Raffeld,et al. A link between increased transforming activity of lymphoma-derived MYC mutant alleles, their defective regulation by p107, and altered phosphorylation of the c-Myc transactivation domain , 1995, Molecular and cellular biology.
[5] Takako Onishi,et al. AMY‐1, a novel C‐MYC binding protein that stimulates transcription activity of C‐MYC , 1998, Genes to cells : devoted to molecular & cellular mechanisms.
[6] J L Cleveland,et al. Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. , 1998, Genes & development.
[7] G. Evan,et al. Induction of TNF‐sensitive cellular phenotype by c‐Myc involves p53 and impaired NF‐κB activation , 1997, The EMBO journal.
[8] J. Bartek,et al. Mutual requirement of CDK4 and Myc in malignant transformation: evidence for cyclin D1/CDK4 and p16INK4A as upstream regulators of Myc , 1997, Oncogene.
[9] A. Sparks,et al. Identification of c-MYC as a target of the APC pathway. , 1998, Science.
[10] S. Goff,et al. Signaling through the ARK tyrosine kinase receptor protects from apoptosis in the absence of growth stimulation , 1997, Oncogene.
[11] A. Nienhuis,et al. An oligomer complementary to c-myc mRNA inhibits proliferation of HL-60 promyelocytic cells and induces differentiation , 1988, Molecular and cellular biology.
[12] A. Porter,et al. Cyclin D3 sensitizes tumor cells to tumor necrosis factor-induced, c-Myc-dependent apoptosis , 1996, Molecular and cellular biology.
[13] Y. Lazebnik,et al. Oncogene-dependent apoptosis in extracts from drug-resistant cells. , 1997, Genes & development.
[14] G. Evan,et al. Apoptosis of rat vascular smooth muscle cells is regulated by p53-dependent and -independent pathways. , 1995, Circulation research.
[15] Xiaodong Wang,et al. Bid, a Bcl2 Interacting Protein, Mediates Cytochrome c Release from Mitochondria in Response to Activation of Cell Surface Death Receptors , 1998, Cell.
[16] M. Aigle,et al. Yeast mutant affected for viability upon nutrient starvation: Characterization and cloning of the RVS161 gene , 1991, Yeast.
[17] T. Tsuruo,et al. c-Myc plays a role in cellular susceptibility to death receptor-mediated and chemotherapy-induced apoptosis in human monocytic leukemia U937 cells , 1997, Oncogene.
[18] G. Evan,et al. Oncogenes and cell death. , 1994, Current opinion in genetics & development.
[19] Seamus J. Martin,et al. Protease activation during apoptosis: Death by a thousand cuts? , 1995, Cell.
[20] L. Williams,et al. A Fas-associated protein factor, FAF1, potentiates Fas-mediated apoptosis. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[21] C. Sherr,et al. Tumor surveillance via the ARF-p53 pathway. , 1998, Genes & development.
[22] G. Mcmahon,et al. Regulation of Myc-dependent apoptosis by p53, c-Jun N-terminal kinases/stress-activated protein kinases, and Mdm-2. , 1997, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[23] D. Bergstrom,et al. Participation of cyclin A in Myc-induced apoptosis. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[24] C. Dang,et al. Binding and suppression of the Myc transcriptional activation domain by p107. , 1994, Science.
[25] R. Roeder,et al. An alternative pathway for transcription initiation involving TFII-I , 1993, Nature.
[26] L. M. Facchini,et al. Dysfunction of the Myc-induced apoptosis mechanism accompanies c-myc activation in the tumorigenic L929 cell line. , 1994, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[27] J. Greene,et al. Activation and repression of mammalian gene expression by the c-myc protein. , 1987, Genes & development.
[28] M. Aigle,et al. Genetic and functional relationship between Rvsp, myosin and actin in Saccharomyces cerevisiae , 1998, Current Genetics.
[29] P. Farnham,et al. c-Myc target gene specificity is determined by a post-DNAbinding mechanism. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[30] T. Graeber,et al. Modulation of c-Myc activity and apoptosis in vivo. , 1996, Cancer research.
[31] J. Sedivy,et al. Transactivation-defective c-MycS retains the ability to regulate proliferation and apoptosis. , 1998, Genes & development.
[32] G. Evan,et al. p53-dependent impairment of T-cell proliferation in FADD dominant-negative transgenic mice , 1998, Current Biology.
[33] D. Beach,et al. Cdc25 cell-cycle phosphatase as a target of c-myc , 1996, Nature.
[34] B. Amati,et al. Myc and the cell cycle. , 1998, Frontiers in bioscience : a journal and virtual library.
[35] M. Hengstschläger,et al. Deregulated expression of CDK2- or CDK3-associated kinase activities enhances c-Myc-induced apoptosis. , 1998, DNA and cell biology.
[36] J. Ashwell,et al. Cyclosporin A-Sensitive Transcription Factor Egr-3 Regulates Fas Ligand Expression , 1998, Molecular and Cellular Biology.
[37] Francesco Cecconi,et al. Apaf1 (CED-4 Homolog) Regulates Programmed Cell Death in Mammalian Development , 1998, Cell.
[38] R A Jungmann,et al. c-Myc transactivation of LDH-A: implications for tumor metabolism and growth. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[39] P. McPherson,et al. Multiple Amphiphysin II Splice Variants Display Differential Clathrin Binding: Identification of Two Distinct Clathrin‐Binding Sites , 1998, Journal of neurochemistry.
[40] R. Eisenman,et al. Transcriptional activities of the Myc and Max proteins in mammalian cells. , 1992, Current topics in microbiology and immunology.
[41] D. Spandidos,et al. Rodent fibroblast tumours expressing human myc and ras genes: growth, metastasis and endogenous oncogene expression. , 1987, British Journal of Cancer.
[42] G. Núñez,et al. WD-40 Repeat Region Regulates Apaf-1 Self-association and Procaspase-9 Activation* , 1998, The Journal of Biological Chemistry.
[43] H. Hermeking,et al. Role of c-myc in simian virus 40 large tumor antigen-induced DNA synthesis in quiescent 3T3-L1 mouse fibroblasts. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[44] M. Pagano,et al. Differential modulation of cyclin gene expression by MYC. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[45] Eric Wickstrom,et al. A c-myc antisense oligodeoxynucleotide inhibits entry into S phase but not progress from G0 to G1 , 1987, Nature.
[46] S. Nagata,et al. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD , 1998, Nature.
[47] M. Schwartz,et al. Integrin regulation of c-Abl tyrosine kinase activity and cytoplasmic-nuclear transport. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[48] U. Siebenlist,et al. The regulation and expression of c-myc in normal and malignant cells. , 1986, Annual review of immunology.
[49] P. De Camilli,et al. A role of amphiphysin in synaptic vesicle endocytosis suggested by its binding to dynamin in nerve terminals. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[50] E. Prochownik,et al. Distinct Roles for MAX Protein Isoforms in Proliferation and Apoptosis* , 1997, The Journal of Biological Chemistry.
[51] C. Y. Wang,et al. Requirement of NF-kappaB activation to suppress p53-independent apoptosis induced by oncogenic Ras. , 1997, Science.
[52] L. Andersson,et al. Ornithine decarboxylase activity is critical for cell transformation , 1992, Nature.
[53] P. Scheurich,et al. Dominant-negative FADD inhibits TNFR60-, Fas/Apo1- and TRAIL-R/Apo2-mediated cell death but not gene induction , 1998, Current Biology.
[54] H. Ding,et al. Oncogene-dependent Regulation of Caspase Activation by p53 Protein in a Cell-free System* , 1998, The Journal of Biological Chemistry.
[55] D. Chao,et al. BCL-2 family: regulators of cell death. , 1998, Annual review of immunology.
[56] John R. Yates,et al. Tra1p Is a Component of the Yeast Ada·Spt Transcriptional Regulatory Complexes* , 1998, The Journal of Biological Chemistry.
[57] K. Miyazono,et al. ASK1 is essential for JNK/SAPK activation by TRAF2. , 1998, Molecular cell.
[58] H. Varmus,et al. Definition of regions in human c-myc that are involved in transformation and nuclear localization , 1987, Molecular and cellular biology.
[59] C. Rudolph,et al. Accelerated proliferative senescence of rat embryo fibroblasts after stable transfection of multiple copies of the c-Myc DNA-binding sequence. , 1998, Experimental cell research.
[60] J. Cleveland,et al. A role for c-myc in chemically induced renal-cell death , 1997, Molecular and cellular biology.
[61] D. Sterner,et al. The SAGA unfolds: convergence of transcription regulators in chromatin-modifying complexes. , 1998, Trends in cell biology.
[62] K. Alitalo,et al. c‐Myc induces cellular susceptibility to the cytotoxic action of TNF‐alpha. , 1994, The EMBO journal.
[63] M. Peter,et al. Advances in apoptosis research. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[64] J. Lotem,et al. A mutant p53 antagonizes the deregulated c-myc-mediated enhancement of apoptosis and decrease in leukemogenicity. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[65] C. Sawyers,et al. Dominant negative MYC blocks transformation by ABL oncogenes , 1992, Cell.
[66] F M Watt,et al. c-Myc promotes differentiation of human epidermal stem cells. , 1997, Genes & development.
[67] S. Frisch,et al. Disruption of epithelial cell-matrix interactions induces apoptosis , 1994, The Journal of cell biology.
[68] S. Srinivasula,et al. Cytochrome c and dATP-Dependent Formation of Apaf-1/Caspase-9 Complex Initiates an Apoptotic Protease Cascade , 1997, Cell.
[69] G. Evan,et al. Inhibition of Ced-3/ICE-related Proteases Does Not Prevent Cell Death Induced by Oncogenes, DNA Damage, or the Bcl-2 Homologue Bak , 1997, The Journal of cell biology.
[70] Kristina D. Micheva,et al. Identification and Characterization of a Nerve Terminal-enriched Amphiphysin Isoform* , 1997, The Journal of Biological Chemistry.
[71] John Calvin Reed,et al. Bcl-2 family proteins and mitochondria. , 1998, Biochimica et biophysica acta.
[72] Y. Lazebnik,et al. Caspases: enemies within. , 1998, Science.
[73] G. Evan,et al. The opposing roles of the Akt and c-Myc signalling pathways in survival from CD95-mediated apoptosis , 1998, Oncogene.
[74] G. Stark,et al. MYC Abrogates p53-Mediated Cell Cycle Arrest in N-(Phosphonacetyl)-l-Aspartate-Treated Cells, Permitting CAD Gene Amplification , 1998, Molecular and Cellular Biology.
[75] J. Sedivy,et al. Phenotypes of c-Myc-deficient rat fibroblasts isolated by targeted homologous recombination. , 1997, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[76] Xiaodong Wang,et al. DFF, a Heterodimeric Protein That Functions Downstream of Caspase-3 to Trigger DNA Fragmentation during Apoptosis , 1997, Cell.
[77] E. Dropcho. Antiamphiphysin antibodies with small‐cell lung carcinoma and paraneoplastic encephalomyelitis , 1996, Annals of neurology.
[78] A. Tokunaga,et al. cDNA cloning of a novel amphiphysin isoform and tissue-specific expression of its multiple splice variants. , 1997, Biochemical and biophysical research communications.
[79] D. Ganem,et al. Apoptosis is induced by N-myc expression in hepatocytes, a frequent event in hepadnavirus oncogenesis, and is blocked by insulin-like growth factor II , 1996, Journal of virology.
[80] J. Cheng,et al. Amplification and overexpression of the AKT2 oncogene in a subset of human pancreatic ductal adenocarcinomas , 1998, Molecular carcinogenesis.
[81] C. Dang,et al. A link between c-Myc-mediated transcriptional repression and neoplastic transformation. , 1996, The Journal of clinical investigation.
[82] M. Cole,et al. The Novel ATM-Related Protein TRRAP Is an Essential Cofactor for the c-Myc and E2F Oncoproteins , 1998, Cell.
[83] D. Clemmons,et al. Blocking ligand occupancy of the αVβ3 integrin inhibits insulin-like growth factor I signaling in vascular smooth muscle cells , 1998 .
[84] W. Ansorge,et al. Activation of cyclin‐dependent kinases by Myc mediates induction of cyclin A, but not apoptosis. , 1996, The EMBO journal.
[85] M. Arsura,et al. Inhibition of c-myc expression induces apoptosis of WEHI 231 murine B cells , 1996, Molecular and cellular biology.
[86] R. Johnston,et al. Quiescence versus apoptosis: Myc abundance determines pathway of exit from the cell cycle , 1998, Oncogene.
[87] A. Giaccia,et al. Direct evidence that apoptosis enhances tumor responses to fractionated radiotherapy. , 1998, Cancer research.
[88] C. Ascoli,et al. Identification of a novel nuclear domain , 1991, The Journal of cell biology.
[89] M. Czaja,et al. c‐myc‐dependent hepatoma cell apoptosis results from oxidative stress and not a deficiency of growth factors , 1997, Journal of cellular physiology.
[90] R. Eisenman,et al. Myc target genes. , 1997, Trends in biochemical sciences.
[91] M. Czech,et al. Stimulation of IRS-1-associated Phosphatidylinositol 3-Kinase and Akt/Protein Kinase B but Not Glucose Transport by β1-Integrin Signaling in Rat Adipocytes* , 1998, The Journal of Biological Chemistry.
[92] P. Camilli,et al. Amphiphysin II (SH3P9; BIN1), a Member of the Amphiphysin/Rvs Family, Is Concentrated in the Cortical Cytomatrix of Axon Initial Segments and Nodes of Ranvier in Brain and around T Tubules in Skeletal Muscle , 1997, The Journal of cell biology.
[93] G. Evan,et al. Transcriptional activation by the human c-Myc oncoprotein in yeast requires interaction with Max , 1992, Nature.
[94] M. Henriksson,et al. Proteins of the Myc network: essential regulators of cell growth and differentiation. , 1996, Advances in cancer research.
[95] P. De Camilli,et al. Autoimmunity in Stiff‐Man Syndrome with breast cancer is targeted to the C‐terminal region of human amphiphysin, a protein similar to the yeast proteins, Rvs167 and Rvs161 , 1994, FEBS letters.
[96] V. Dixit,et al. Death receptors: signaling and modulation. , 1998, Science.
[97] D. Goeddel,et al. Early lethality, functional NF-kappaB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice. , 1997, Immunity.
[98] Junying Yuan,et al. Cleavage of BID by Caspase 8 Mediates the Mitochondrial Damage in the Fas Pathway of Apoptosis , 1998, Cell.
[99] E. Prochownik,et al. Differential patterns of DNA binding by myc and max proteins. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[100] C. Kumar,et al. Signaling by integrin receptors , 1998, Oncogene.
[101] D. McDonald,et al. Nuclear-cytoplasmic shuttling of C-ABL tyrosine kinase. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[102] G. Prendergast,et al. c‐Myc represses transcription in vivo by a novel mechanism dependent on the initiator element and Myc box II. , 1994, The EMBO journal.
[103] D. Goeddel,et al. FADD: essential for embryo development and signaling from some, but not all, inducers of apoptosis. , 1998, Science.
[104] Robert Wechsler-Reya,et al. BIN1 is a novel MYC–interacting protein with features of a tumour suppressor , 1996, Nature Genetics.
[105] J. Cleveland,et al. v-Raf/v-Myc synergism in abrogation of IL-3 dependence: v-Raf suppresses apoptosis. , 1992, Current topics in microbiology and immunology.
[106] M. Scheid,et al. Dissociation of cytokine-induced phosphorylation of Bad and activation of PKB/akt: involvement of MEK upstream of Bad phosphorylation. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[107] Jean-Claude Martinou,et al. Bax-induced Cytochrome C Release from Mitochondria Is Independent of the Permeability Transition Pore but Highly Dependent on Mg2+ Ions , 1998, The Journal of cell biology.
[108] A. Pendergast,et al. The amphiphysin-like protein 1 (ALP1) interacts functionally with the cABL tyrosine kinase and may play a role in cytoskeletal regulation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[109] P. Watson,et al. Relationship of c-myc amplification to progression of breast cancer from in situ to invasive tumor and lymph node metastasis. , 1993, Journal of the National Cancer Institute.
[110] K. Ryan,et al. Cell-cycle progression is not essential for c-Myc to block differentiation , 1997, Oncogene.
[111] D. Green. Apoptotic Pathways The Roads to Ruin , 1998, Cell.
[112] David E. Housman,et al. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours , 1996, Nature.
[113] D. Baltimore,et al. Activation of apoptosis signal-regulating kinase 1 (ASK1) by the adapter protein Daxx. , 1998, Science.
[114] David L. Vaux,et al. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells , 1988, Nature.
[115] S. Chen,et al. Diva, a Bcl-2 Homologue that Binds Directly to Apaf-1 and Induces BH3-independent Cell Death* , 1998, The Journal of Biological Chemistry.
[116] G. Prendergast,et al. The polyproline region of p53 is required to activate apoptosis but not growth arrest , 1997, Oncogene.
[117] M. Peter,et al. Two CD95 (APO‐1/Fas) signaling pathways , 1998, The EMBO journal.
[118] Didier Picard,et al. Chimaeras of Myc oncoprotein and steroid receptors cause hormone-dependent transformation of cells , 1989, Nature.
[119] A. Giaccia,et al. Transformed cells require continuous activity of RNA polymerase II to resist oncogene-induced apoptosis , 1997, Molecular and cellular biology.
[120] S. Cory,et al. The Bcl-2 protein family: arbiters of cell survival. , 1998, Science.
[121] K. Alitalo,et al. Repression of cyclin D1: a novel function of MYC. , 1994, Molecular and cellular biology.
[122] D. Green,et al. DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T lymphocytes via the activation of NF-kappa B and AP-1. , 1998, Molecular cell.
[123] John Calvin Reed,et al. The novel primary response gene MyD118 and the proto-oncogenes myb, myc, and bcl-2 modulate transforming growth factor beta 1-induced apoptosis of myeloid leukemia cells. , 1994, Molecular and cellular biology.
[124] H. McMahon,et al. Inhibition of receptor-mediated endocytosis by the amphiphysin SH3 domain , 1997, Current Biology.
[125] N. Kyprianou,et al. Therapeutic Approaches to Activating Programmed Cell Death of Androgen-Independent Prostatic Cancer Cells , 1991 .
[126] Yufang Shi,et al. Fungal metabolite FR901228 inhibits c-Myc and Fas ligand expression , 1998, Oncogene.
[127] Gwyn T. Williams. Programmed cell death: Apoptosis and oncogenesis , 1991, Cell.
[128] M. Rose,et al. Rvs161p Interacts with Fus2p to Promote Cell Fusion in Saccharomyces cerevisiae , 1998, The Journal of cell biology.
[129] M. Méchali,et al. c-Myc in the control of cell proliferation and embryonic development. , 1996, Advances in cancer research.
[130] J. Parsons,et al. Src family protein tyrosine kinases: cooperating with growth factor and adhesion signaling pathways. , 1997, Current opinion in cell biology.
[131] V. Dixit,et al. Caspase-9, Bcl-XL, and Apaf-1 Form a Ternary Complex* , 1998, The Journal of Biological Chemistry.
[132] S. Lowe,et al. E1A signaling to p53 involves the p19(ARF) tumor suppressor. , 1998, Genes & development.
[133] G. Prendergast,et al. Association of Myn, the murine homolog of Max, with c-Myc stimulates methylation-sensitive DNA binding and ras cotransformation , 1991, Cell.
[134] R. Eisenman,et al. Myc and Max Homologs in Drosophila , 1996, Science.
[135] Bruno Amati,et al. Oncogenic activity of the c-Myc protein requires dimerization with Max , 1993, Cell.
[136] Liang Zhu,et al. Interaction of c‐Myc with the pRb‐related protein p107 results in inhibition of c‐Myc‐mediated transactivation. , 1994, The EMBO journal.
[137] G. Prendergast,et al. Evidence that farnesyltransferase inhibitors suppress Ras transformation by interfering with Rho activity , 1995, Molecular and cellular biology.
[138] P. O'dwyer,et al. Apoptosis in human adenocarcinoma HT29 cells induced by exposure to hypoxia. , 1995, Journal of the National Cancer Institute.
[139] E. Liu,et al. Identification of a large Myc-binding protein that contains RCC1-like repeats. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[140] G. Evan,et al. Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB , 1997, Nature.
[141] M. Aigle,et al. Alteration of a yeast SH3 protein leads to conditional viability with defects in cytoskeletal and budding patterns , 1993, Molecular and cellular biology.
[142] E Ruoslahti,et al. Integrins and anoikis. , 1997, Current opinion in cell biology.
[143] K. Klempnauer,et al. Sequence-specific DNA binding by Myc proteins. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[144] D. Brough,et al. An essential domain of the c-myc protein interacts with a nuclear factor that is also required for E1A-mediated transformation , 1995, Molecular and cellular biology.
[145] P. Farnham,et al. An E-box-mediated increase in cad transcription at the G1/S-phase boundary is suppressed by inhibitory c-Myc mutants , 1995, Molecular and cellular biology.
[146] Asim Khwaja,et al. Matrix adhesion and Ras transformation both activate a phosphoinositide 3‐OH kinase and protein kinase B/Akt cellular survival pathway , 1997, The EMBO journal.
[147] L. Peso,et al. Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. , 1997, Science.
[148] P. Nowell,et al. Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation. , 1984, Science.
[149] R. Eisenman,et al. Myc and Max proteins possess distinct transcriptional activities , 1992, Nature.
[150] D. Fisher,et al. Loss of Matrix Adhesion Triggers Rapid Transformation-Selective Apoptosis in Fibroblasts , 1997, The Journal of cell biology.
[151] M. Cole,et al. c-myc null cells misregulate cad and gadd45 but not other proposed c-Myc targets. , 1998, Genes & development.
[152] D. Hehir,et al. C‐myc oncogene expression: A marker for females at risk of breast carcinoma , 1993, Journal of surgical oncology.
[153] J P Luzio,et al. Cell surface trafficking of Fas: a rapid mechanism of p53-mediated apoptosis. , 1998, Science.
[154] K. Zerres,et al. Enhanced apoptotic cell death of renal epithelial cells in mice lacking transcription factor AP-2beta. , 1997, Genes & development.
[155] M. Schwab,et al. MycN and IFNγ cooperate in apoptosis of human neuroblastoma cells , 1998, Oncogene.
[156] D. Green,et al. Regulation of Fas-Ligand Expression during Activation-induced Cell Death in T Lymphocytes via Nuclear Factor κB* , 1999, The Journal of Biological Chemistry.
[157] J. Cleveland,et al. Induction of ornithine decarboxylase by IL-3 is mediated by sequential c-Myc-independent and c-Myc-dependent pathways , 1997, Oncogene.
[158] Richard O. Hynes,et al. Integrin-mediated Signals Regulated by Members of the Rho Family of GTPases , 1998, The Journal of cell biology.
[159] Xiaodong Wang,et al. Apaf-1, a Human Protein Homologous to C. elegans CED-4, Participates in Cytochrome c–Dependent Activation of Caspase-3 , 1997, Cell.
[160] K. Alitalo,et al. Alternative Forms of Max as Enhancers or Suppressors of Myc-Ras Cotransformation , 1992, Science.
[161] J. Foekens,et al. Receptors for hormones and growth factors and (ONCO)‐gene amplification in human ovarian cancer , 1992, International journal of cancer.
[162] W. Gu,et al. Opposite regulation of gene transcription and cell proliferation by c-Myc and Max. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[163] G. Evan,et al. Requirement for the CD95 receptor-ligand pathway in c-Myc-induced apoptosis. , 1997, Science.
[164] J. Sedivy,et al. Effects of c-myc expression on cell cycle progression , 1994, Molecular and cellular biology.
[165] A. Strasser,et al. Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2 , 1990, Nature.
[166] S. R. Datta,et al. Akt Phosphorylation of BAD Couples Survival Signals to the Cell-Intrinsic Death Machinery , 1997, Cell.
[167] J. Cleveland,et al. c-Myc and apoptosis. , 1995, Biochimica et biophysica acta.
[168] K. Bhatia,et al. A role for deregulated c-Myc expression in apoptosis of Epstein-Barr virus-immortalized B cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[169] H. Hermeking,et al. Mediation of c-Myc-induced apoptosis by p53. , 1994, Science.
[170] L. Williams,et al. Tumor necrosis factor α‐induced activation of c‐jun N‐terminal kinase is mediated by TRAF2 , 1997, The EMBO journal.
[171] N. Kyprianou,et al. Programmed cell death during regression of PC-82 human prostate cancer following androgen ablation. , 1990, Cancer research.
[172] E. Prochownik,et al. Differential apoptotic behaviors of c-myc, N-myc, and L-myc oncoproteins. , 1998, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[173] A. Wyllie,et al. Apoptosis (the 1992 Frank Rose Memorial Lecture). , 1993, British Journal of Cancer.
[174] R. Eisenman,et al. Myc and Max associate in vivo. , 1992, Genes & development.
[175] G. Evan,et al. The role of c-myc in cell growth. , 1993, Current opinion in genetics & development.
[176] M. Cole. The myc oncogene: its role in transformation and differentiation. , 1986, Annual review of genetics.
[177] C. Dang,et al. A unique glucose-dependent apoptotic pathway induced by c-Myc. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[178] Jacques Landry,et al. SAPK2/p38-dependent F-Actin Reorganization Regulates Early Membrane Blebbing during Stress-induced Apoptosis , 1998, The Journal of cell biology.
[179] O. Warburg. [Origin of cancer cells]. , 1956, Oncologia.
[180] L. M. Facchini,et al. The molecular role of Myc in growth and transformation: recent discoveries lead to new insights , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[181] J. Beckmann,et al. Targeted disruption of the mouse Caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally. , 1998, Immunity.
[182] G. Prendergast,et al. A Role for the Putative Tumor Suppressor Bin1 in Muscle Cell Differentiation , 1998, Molecular and Cellular Biology.
[183] R. DePinho,et al. Drosophila Myc is oncogenic in mammalian cells and plays a role in the diminutive phenotype. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[184] F. Kaye,et al. The N-terminal domain of c-Myc associates with alpha-tubulin and microtubules in vivo and in vitro , 1995, Molecular and cellular biology.
[185] T. Mak,et al. Apaf1 Is Required for Mitochondrial Pathways of Apoptosis and Brain Development , 1998, Cell.
[186] A. Levine. The tumor suppressor genes. , 1993, Annual review of biochemistry.
[187] C. Thompson,et al. Bcl-2-family proteins: the role of the BH3 domain in apoptosis. , 1998, Trends in cell biology.
[188] G. Prendergast,et al. Biphasic effect of Max on Myc cotransformation activity and dependence on amino- and carboxy-terminal Max functions. , 1992, Genes & development.
[189] D. Thorley-Lawson,et al. A novel form of Epstein-Barr virus latency in normal B cells in vivo , 1995, Cell.
[190] J Downward,et al. Ras signalling and apoptosis. , 1998, Current opinion in genetics & development.
[191] D. Bostwick,et al. Detection of c-myc oncogene amplification and chromosomal anomalies in metastatic prostatic carcinoma by fluorescence in situ hybridization. , 1997, Cancer research.
[192] D. Slamon,et al. Proto-oncogenes and tumor suppressor genes in human urological malignancies. , 1994, The Journal of urology.
[193] G. G. Stokes. "J." , 1890, The New Yale Book of Quotations.
[194] G. Prendergast,et al. Structural Analysis of the Human BIN1 Gene , 1997, The Journal of Biological Chemistry.
[195] G. Koretzky,et al. Stress-Induced Fas Ligand Expression in T Cells Is Mediated through a MEK Kinase 1-Regulated Response Element in the Fas Ligand Promoter , 1998, Molecular and Cellular Biology.
[196] R. Johnston,et al. Apoptosis induced by c-myc overexpression is dependent on growth conditions. , 1995, Experimental cell research.
[197] A. Porter,et al. Nuclear c-Myc plays an important role in the cytotoxicity of tumor necrosis factor alpha in tumor cells , 1994, Molecular and cellular biology.
[198] G. Evan,et al. Identification of domains of the insulin-like growth factor I receptor that are required for protection from apoptosis , 1997, Molecular and cellular biology.
[199] C. Dang,et al. Max: functional domains and interaction with c-Myc. , 1992, Genes & development.
[200] K. Ryan,et al. Myc oncogenes: the enigmatic family. , 1996, The Biochemical journal.
[201] Y. Lazebnik,et al. Oncogene-dependent apoptosis is mediated by caspase-9. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[202] R. DePinho,et al. Myc family oncoproteins function through a common pathway to transform normal cells in culture: cross-interference by Max and trans-acting dominant mutants. , 1992, Genes & development.
[203] J. Blenis,et al. Essential requirement for caspase-8/FLICE in the initiation of the Fas-induced apoptotic cascade , 1998, Current Biology.
[204] M. Aigle,et al. Cloning of the Multicopy Suppressor Gene SUR7: Evidence for a Functional Relationship between the Yeast Actin‐binding Protein Rvs167 and a Putative Membranous Protein , 1998, Yeast.
[205] M. Eilers,et al. Control of cell proliferation by Myc. , 1998, Trends in cell biology.
[206] G. Evan,et al. Apoptosis and the cell cycle. , 1995, Current opinion in cell biology.
[207] M. Herlyn,et al. The putative tumor suppressor BIN1 is a short-lived nuclear phosphoprotein, the localization of which is altered in malignant cells. , 1997, Cancer research.
[208] Gerard I. Evan,et al. Induction of apoptosis in fibroblasts by c-myc protein , 1992, Cell.
[209] K. Noguchi,et al. A functional role for death proteases in s-Myc- and c-Myc-mediated apoptosis , 1997, Molecular and cellular biology.
[210] G. Evan,et al. A matter of life and cell death. , 1998, Science.
[211] G. Prendergast. Myc Structure and Function , 1997 .
[212] M. Welsh,et al. Depletion of c-myc with specific antisense sequences reverses the transformed phenotype in ras oncogene-transformed NIH 3T3 cells , 1991, Molecular and cellular biology.
[213] Stephen K. Burley,et al. Recognition by Max of its cognate DNA through a dimeric b/HLH/Z domain , 1993, Nature.
[214] Chi V. Dang,et al. c-Myc Target Genes Involved in Cell Growth, Apoptosis, and Metabolism , 1999, Molecular and Cellular Biology.
[215] J. Yuan,et al. Evolutionary conservation of a genetic pathway of programmed cell death , 1996, Journal of cellular biochemistry.
[216] M. Fernö,et al. c‐myc amplification is an independent prognostic factor in postmenopausal breast cancer , 1992, International journal of cancer.
[217] M. Cole,et al. Casein kinase II inhibits the DNA-binding activity of Max homodimers but not Myc/Max heterodimers. , 1992, Genes & development.
[218] J C Reed,et al. Mitochondria and apoptosis. , 1998, Science.
[219] S. Lowe,et al. Essential contribution of caspase 3/CPP32 to apoptosis and its associated nuclear changes. , 1998, Genes & development.
[220] J. Frost,et al. c-Myc cooperates with activated Ras to induce the cdc2 promoter , 1994, Molecular and cellular biology.
[221] S Gaubatz,et al. An E-box element localized in the first intron mediates regulation of the prothymosin alpha gene by c-myc , 1994, Molecular and cellular biology.
[222] G. Evan,et al. The c‐Myc protein induces cell cycle progression and apoptosis through dimerization with Max. , 1993, The EMBO journal.
[223] P. Pandolfi,et al. Pml is essential for multiple apoptotic pathways , 1998, Nature Genetics.
[224] H. McMahon,et al. Crystal structure of the amphiphysin‐2 SH3 domain and its role in the prevention of dynamin ring formation , 1998, The EMBO journal.
[225] J. Cleveland,et al. Ornithine decarboxylase is a mediator of c-Myc-induced apoptosis , 1994, Molecular and cellular biology.
[226] N. Hay,et al. Myc-mediated apoptosis requires wild-type p53 in a manner independent of cell cycle arrest and the ability of p53 to induce p21waf1/cip1. , 1994, Genes & development.
[227] H. Horvitz,et al. Genetics of programmed cell death in C. elegans: past, present and future. , 1998, Trends in genetics : TIG.
[228] V. Rotter,et al. c-Myc trans-activates the p53 promoter through a required downstream CACGTG motif. , 1993, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[229] J A Moshier,et al. Transformation of NIH/3T3 cells by ornithine decarboxylase overexpression. , 1993, Cancer research.
[230] D. Green,et al. Role for c-myc in activation-induced apoptotic cell death in T cell hybridomas. , 1992, Science.
[231] H. Horvitz,et al. Mechanisms and functions of cell death. , 1991, Annual review of cell biology.
[232] T. Halazonetis,et al. Determination of the c-MYC DNA-binding site. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[233] I. Garkavtsev,et al. A novel candidate tumor suppressor, ING1, is involved in the regulation of apoptosis. , 1997, Cancer research.
[234] H. Weintraub,et al. Sequence-specific DNA binding by the c-Myc protein. , 1990, Science.
[235] B. de Crombrugghe,et al. Transcriptional suppression of cellular gene expression by c-Myc , 1991, Molecular and cellular biology.
[236] J. Brugge,et al. Phosphatidylinositol 3-kinase is required for integrin-stimulated AKT and Raf-1/mitogen-activated protein kinase pathway activation , 1997, Molecular and cellular biology.
[237] A. Fornace,et al. Myc represses the growth arrest gene gadd45 , 1997, Oncogene.
[238] R. Perry,et al. Role of c-myc in tamoxifen-induced apoptosis estrogen-independent breast cancer cells. , 1996, Journal of the National Cancer Institute.
[239] H. Perlman,et al. Overexpression of bcl-2 protects prostate cancer cells from apoptosis in vitro and confers resistance to androgen depletion in vivo. , 1995, Cancer research.
[240] L. Shantz,et al. Overproduction of ornithine decarboxylase caused by relief of translational repression is associated with neoplastic transformation. , 1994, Cancer research.
[241] N. Rosen,et al. Cyclin D Expression Is Controlled Post-transcriptionally via a Phosphatidylinositol 3-Kinase/Akt-dependent Pathway* , 1998, The Journal of Biological Chemistry.
[242] P. Watson,et al. c-myc oncogene expression in estrogen-dependent and -independent breast cancer. , 1993, Clinical chemistry.
[243] John Calvin Reed,et al. Regulation of cell death protease caspase-9 by phosphorylation. , 1998, Science.
[244] A. Wyllie,et al. Apoptosis: A Basic Biological Phenomenon with Wide-ranging Implications in Tissue Kinetics , 1972, British Journal of Cancer.
[245] M. Groudine,et al. Control of c-myc regulation in normal and neoplastic cells. , 1991, Advances in cancer research.
[246] E. Hölttä,et al. Involvement of CPP32/Caspase-3 in c-Myc-induced apoptosis , 1998, Oncogene.
[247] M. Raff,et al. Social controls on cell survival and cell death , 1992, Nature.
[248] D. Soprano,et al. Overexpression of Mxi1 inhibits the induction of the human ornithine decarboxylase gene by the Myc/Max protein complex. , 1996, Oncogene.
[249] G. Prendergast,et al. Methylation-sensitive sequence-specific DNA binding by the c-Myc basic region. , 1991, Science.
[250] J L Cleveland,et al. The ornithine decarboxylase gene is a transcriptional target of c-Myc. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[251] M. Barone,et al. Myc but not Fos rescue of PDGF signalling block caused by kinase-inactive Src , 1995, Nature.
[252] D. Litchfield,et al. Rescue from granzyme B-induced apoptosis by Wee1 kinase , 1995, The Journal of experimental medicine.
[253] O. Yanuka,et al. Involvement of Myc targets in c-myc and N-myc induced human tumors , 1998, Oncogene.
[254] D. Green,et al. Apoptotic cell death induced by c-myc is inhibited by bcl-2 , 1992, Nature.
[255] G. Evan,et al. Cooperative interaction between c-myc and bcl-2 proto-oncogenes , 1992, Nature.
[256] C. Ling,et al. Apoptosis in heat-induced cell killing: the protective role of hsp-70 and the sensitization effect of the c-myc gene. , 1996, Radiation research.
[257] M. Hung,et al. c-myc reverses neu-induced transformed morphology by transcriptional repression , 1991, Molecular and cellular biology.
[258] Lewis C Cantley,et al. PI3K: Downstream AKTion Blocks Apoptosis , 1997, Cell.
[259] M. Schwab,et al. The N‐Myc oncoprotein is associated in vivo with the phosphoprotein Max(p20/22) in human neuroblastoma cells. , 1991, The EMBO journal.
[260] G. Evan,et al. c‐Myc‐induced apoptosis in fibroblasts is inhibited by specific cytokines. , 1994, The EMBO journal.
[261] Lianfa Shi,et al. Premature p34cdc2 activation required for apoptosis. , 1994, Science.
[262] Brian J. Stevenson,et al. end5, end6, and end7: mutations that cause actin delocalization and block the internalization step of endocytosis in Saccharomyces cerevisiae. , 1995, Molecular biology of the cell.
[263] G. Natoli,et al. Activation of SAPK/JNK by TNF Receptor 1 Through a Noncytotoxic TRAF2-Dependent Pathway , 1997, Science.
[264] J. Barrett,et al. An amino-terminal c-myc domain required for neoplastic transformation activates transcription , 1990, Molecular and cellular biology.
[265] M. Linial,et al. Viral Myc Oncoproteins in Infected Fibroblasts Down-modulate Thrombospondin-1, a Possible Tumor Suppressor Gene* , 1996, The Journal of Biological Chemistry.
[266] V. D’Agati,et al. C-MYC–induced Apoptosis in Polycystic Kidney Disease Is Bcl-2 and p53 Independent , 1997, The Journal of experimental medicine.
[267] M. Koken,et al. PML induces a novel caspase-independent death process , 1998, Nature Genetics.
[268] N. Kabra,et al. Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/Mort1 , 1998, Nature.
[269] C. Sawyers,et al. The PTEN/MMAC1 tumor suppressor phosphatase functions as a negative regulator of the phosphoinositide 3-kinase/Akt pathway. , 1998, Proceedings of the National Academy of Sciences of the United States of America.